Trial Profile
A randomized control trial on the postoperative application of gemcitabine in patients with radical resection of biliary tract cancers.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Fluorouracil; Oxaliplatin
- Indications Biliary cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Aug 2010 to 31 Aug 2012 as reported by Chinese Clinical Trial Register.
- 18 Aug 2009 New trial record